Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP703669.RADooZMH_33NKX2lq_8skIzoBkq4kOZE25mEev20WCTHs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP703669.RADooZMH_33NKX2lq_8skIzoBkq4kOZE25mEev20WCTHs130_assertion type Assertion NP703669.RADooZMH_33NKX2lq_8skIzoBkq4kOZE25mEev20WCTHs130_head.
- NP703669.RADooZMH_33NKX2lq_8skIzoBkq4kOZE25mEev20WCTHs130_assertion description "[The MAL gene, which has been shown to confer resistance to cancer therapy, was most highly overexpressed in short-term survivors (3-fold compared with long-term survivors, and 29-fold compared with early-stage cases).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP703669.RADooZMH_33NKX2lq_8skIzoBkq4kOZE25mEev20WCTHs130_provenance.
- NP703669.RADooZMH_33NKX2lq_8skIzoBkq4kOZE25mEev20WCTHs130_assertion evidence source_evidence_literature NP703669.RADooZMH_33NKX2lq_8skIzoBkq4kOZE25mEev20WCTHs130_provenance.
- NP703669.RADooZMH_33NKX2lq_8skIzoBkq4kOZE25mEev20WCTHs130_assertion SIO_000772 15897565 NP703669.RADooZMH_33NKX2lq_8skIzoBkq4kOZE25mEev20WCTHs130_provenance.
- NP703669.RADooZMH_33NKX2lq_8skIzoBkq4kOZE25mEev20WCTHs130_assertion wasDerivedFrom befree-20140225 NP703669.RADooZMH_33NKX2lq_8skIzoBkq4kOZE25mEev20WCTHs130_provenance.
- NP703669.RADooZMH_33NKX2lq_8skIzoBkq4kOZE25mEev20WCTHs130_assertion wasGeneratedBy ECO_0000203 NP703669.RADooZMH_33NKX2lq_8skIzoBkq4kOZE25mEev20WCTHs130_provenance.